Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.30 | N/A |
| PEG Ratio (TTM) | -2.17 | N/A |
| P/S Ratio (TTM) | 0.43 | N/A |
| P/B Ratio (TTM) | 3.53 | N/A |
| P/FCF Ratio (TTM) | 66.31 | N/A |
| Price to 5YR AVG Earnings Ratio | 37.49 | N/A |
| Price to 5YR AVG FCF Ratio | 14.48 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.51% | N/A |
| ROE (TTM) | 13.40% | N/A |
| Net Profit Margin (TTM) | 1.54% | N/A |
| ROIC 5YR AVG | 14.33% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 136.93% | 47.57% | 49.84% |
| Revenue | 0.46% | 0.80% | 2.68% |
| Net Income | 138.22% | 47.39% | 49.39% |
| Cash Flow | 14.42% | 8.56% | 50.43% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.28 | N/A |
| Quick Ratio (TTM) | 1.28 | N/A |
| D/E Ratio (TTM) | 1.64 | N/A |
| Interest Coverage (TTM) | 1.91 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.89 | N/A |
| LTL to 5YR AVG FCF | 7.04 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.77% | N/A |